Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy.
- 1 August 2001
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 5 (4) , 302-309
- https://doi.org/10.1034/j.1399-3046.2001.00007.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CONVERSION FROM AZATHIOPRINA TO MYCOPHENOLATE MOFETIL IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH CHRONIC REJECTION1Transplantation, 2000
- Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot studyTransplantation Proceedings, 1999
- The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantationTransplantation Proceedings, 1999
- ADVERSE EFFECTS OF MYCOPHENOLATE MOFETIL IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH PRESUMED CHRONIC REJECTIONTransplantation, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2Transplantation, 1998
- Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experienceTransplantation Proceedings, 1998
- CHRONIC RENAL ALLOGRAFT REJECTIONTransplantation, 1998
- A NOVEL APPROACH TO THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY1Transplantation, 1997
- A simple estimate of glomerular filtration rate in adolescent boysThe Journal of Pediatrics, 1985